GLP-1 agonists and SGLT-2 inhibitors in adults with sickle cell disease

Am J Hematol. 2024 Aug;99(8):1610-1612. doi: 10.1002/ajh.27348. Epub 2024 Apr 24.

Ryan Sun¹, Anand Srivastava², Vimal K Derebail³, Jin Han^{1

4}, Robert E Molokie^{1

5}, Victor Gordeuk¹, Santosh L Saraf¹

¹ Sickle Cell Center, Division of Hematology & Oncology, University of Illinois Chicago, Chicago, Illinois, USA.
² Division of Nephrology, University of Illinois Chicago, Chicago, Illinois, USA.
³ UNC Kidney Center, Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
⁴ Department of Pharmacy Practice, University of Illinois Chicago, Chicago, Illinois, USA.
⁵ Department of Medicine, Jesse Brown VA Medical Center, Chicago, Illinois, USA.

No abstract available

Publication types